Phase 4 Master Protocol for Patients Prescribed Prademagene Zamikeracel for the Treatment of Wounds
← catalyst calendarNCT07717736 · readout ≤ 1,929 d
Sponsored by Abeona Therapeutics, Inc (industry) · ABEO — their whole pipeline →.
Phase
Phase 4
Status
Not yet recruiting
Study type
Interventional
Design
Non randomized · None · Treatment
Enrollment
100estimated
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-19
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | Nov 2026 | estimated | When the study began enrolling |
| Primary completion | Nov 2031 | estimated | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | Jul 2032 | estimated | The whole study's end, after follow-up |
| First posted | 2026-07-21 | actual | When this record first appeared on the registry |
| Results posted | — | When the sponsor posted results to the registry | |
| Record updated | 2026-08-06 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Conditions
- Epidermolysis Bullosa (EB)
- Recessive Dystrophic Epidermolysis Bullosa (RDEB)
- Dystrophic Epidermolysis Bullosa (DEB)
Interventions
- Biological: Non-conforming pz-cel surgical application to RDEB wounds
- Procedure: Additional biopsies
- Biological: Pz-cel surgical application to DEB wounds
Primary outcomes
what the primary-completion date above is the date OFStudy A - Wound Healing ≥50%
measured From Baseline at Week 24 (Month 6)
Study A - Pain Severity Scale (Wong-Baker FACES)
measured At Week 24 (Month 6)
Study C - Wound Healing ≥50%
measured From Baseline at Week 24 (Month 6)
Study C - Pain Severity Scale (Wong-Baker FACES)
measured At Week 24 (Month 6)
Permalink · ABEO's whole pipeline · Catalyst calendar · Every registered study · What changed